CLINICAL STUDIES
The Phoenix CyberKnife Center & Clinical Research
Phoenix CyberKnife and Radiation Oncology Center's board-certified radiation oncologists have participated in numerous studies and clinical trials to further advance the field of radiation oncology and other related medical fields. Here, you will find links to peer-reviewed, published works that they have authored, co-authored, and participated:
Lauren D. Stegman, MD, PhD, DABR
Downloadable PDFs
- Non-Small Cell Lung Cancer - (NSCLC) Guidelines 2014
National Comprehensive Cancer Network - NCCN - Metastatic Rectal Cancer ACR Appropriateness Criteria
- Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
John J. Kresl, MD, PhD, FACRO
- Stereotactic Ablative Radiotherapy versus Lobectomy: A Pooled Analysis of Two Randomised Trials
- The Future of Oncology – The Best of Radiosurgery 2014
- Best of the Radiosurgery Society® Scientific Meeting 2014: stereotactic radiosurgery/stereotactic body radiotherapy treatment of extracranial and intracranial lesions
- Health related quality of life and cognitive status in patients with glioblastoma multiforme
- Hypofractionated CyberKnife radiosurgery for perichiasmatic pituitary adenomas
- A historical perspective of the radiation oncology workforce and ongoing initiatives to affect recruitment and retention
- Spinal cord gliomas: A multi-institutional retrospective analysis
- Sinonasal leiomyosarcoma: review of literature and case report
- Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases
- Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors
- Radiation oncology health care professional shortages
- Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma
- The employment status of 1995 graduates from radiation oncology training programs in the United States
- Inhibition of mouse mammary adenocarcinoma (EMT6) growth and metastases in mice by a modified form of C-reactive protein
- Conversion of native oligomeric to a modified monomeric form of human C-reactive protein
- Postoperative localization of porta hepatis and abdominal vasculature in pancreatic malignancies: implications for postoperative radiotherapy planning
- An immunofiltration apparatus for accelerating the visualization of antigen on membrane supports
- Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer
- Patient-controlled analgesia. A new system for pain management
Lauren D. Stegman, MD, PhD, DABR
- Is smaller better when it comes to the bladder?: in regard to Stewart et al. (Int J Radiat Oncol Biol Phys 2008;72:843-848)
- Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities
- Long-term clinical outcomes of whole-breast irradiation delivered in the prone position
- Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience
- Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy
- Evaluation of (E)-2'-deoxy-2'-(fluoromethylene)cytidine on the 9L rat brain tumor model using MRI
- Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging
- Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors
- Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts
- Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy
- Experimental gliosarcoma induces chemokine receptor expression in rat brain
- Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy
- Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study
- Induction of cytotoxic oxidative stress by D-alanine in brain tumor cells expressing Rhodotorula gracilis D-amino acid oxidase: a cancer gene therapy strategy
- Phylogenetic footprinting of hypersensitive site 3 of the beta-globin locus control region
- In vivo 31P MRS evaluation of ganciclovir toxicity in C6 gliomas stably expressing the herpes simplex thymidine kinase gene
Kurt A. Wharton, MD, DABR
- Pure tubular breast carcinoma: a 34 year study of outcomes
- Sulci density map to aid in use of apparent diffusion coefficient for therapy evaluation